BH3-only proteins in control: Specificity regulates MCL-1 and BAK-mediated apoptosis

Genes and Development

Volumn 19, Issue 11, 2005, Pages 1263-1268

  Gélinas, Céline ^a,c,d   White, Eileen ^a,b,d  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^d RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BH3 PROTEIN; BORTEZOMIB; PROTEIN BAK; PROTEIN BCL XL; PROTEIN MCL 1;

APOPTOSIS; CELL DEATH; GENE EXPRESSION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW;

ANIMALS; APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; HUMANS; MEMBRANE PROTEINS; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 22344456263     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.1326205     Document Type: Review

References (49)

1. Adams, J.M. 2003. Ways of dying: Multiple pathways to apoptosis. Genes & Dev. 17: 2481-2495.
2. Akiyama, T., Bouillet, P., Miyazaki, T., Kadono, Y., Chikuda, H., Chung, U.-I., Fukuda, A., Hikita, A., Seto, H., Okada, T., et al. 2003. Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim. EMBO J. 22: 6653-6664.
3. Campbell, K.J., Rocha, S., and Perkins, N.D. 2004. Active repression of antiapoptotic gene expression by RelA(p65) NF-κ B. Mol. Cell 13: 853-865.
4. Chen, L., Willis, S.N., Wei, A., Smith, B.J., Fletcher, J.I., Hinds, M.G., Colman, P.M., Day, C.L., Adams, J.M., and Huang, D.C.S. 2005. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol. Cell 17: 393-403.
5. L sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol. Cell 8: 705-711.
6. Cheng, E.H., Sheiko, T.V., Fisher, J.K., Craigen, W.J., and Korsmeyer, S.J. 2003. VDAC2 inhibits BAK activation and mitochondrial apoptosis. Science 301: 513-517.
7. Cory, S., Huang, D.C., and Adams, J.M. 2003. The Bcl-2 family: Roles in cell survival and oncogenesis. Oncogene 22: 8590-8607.
8. Cuconati, A. and White, E. 2002. Viral homologues of Bcl-2: Role of apoptosis in the regulation of virus infection. Genes & Dev. 16: 2465-2478.
9. Cuconati, A., Mukherjee, C., Perez, D., and White, E. 2003. DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells. Genes & Dev. 17: 2922-2932.
10. Danial, N.N. and Korsmeyer, S.J. 2004. Cell death: Critical control points. Cell 116: 205-219.
11. Day, C.L., Chen, L., Richardson, S.J., Harrison, P.J., Huang, D.C.S., and Hind, M.G. 2005. Solution structure of prosurvival Mcl-1 and characterization of its binding by proapoptotic BH3-only ligands. J. Biol. Chem. 280: 4738-4744.
12. Degenhardt, K., Chen, G., Lindsten, T., and White, E. 2002a. Bax and Bak mediate p53-independent suppression of tumorigenesis. Cancer Cell 2: 193-203.
13. Degenhardt, K., Sundararajan, R., Lindsten, T., Thompson, C.B., and White, E. 2002b. Bax and Bak independently promote cytochrome-c release from mitochondria. J. Biol. Chem. 277: 14127-14134.
14. Egle, A., Harris, A.L., Bouillet, P., and Cory, S. 2004. Bim is a suppressor of Myc-induced mouse B cell leukemia. Proc. Natl. Acad. Sci. 101: 6164-6169.
15. Hemann, M.T., Zilfou, J.T., Zhao, Z., Bugess, D.J., Hannon, G.J., and Lowe, S.W. 2004. Suppression of tumorigenesis by the p53 target PUMA. Proc. Natl. Acad. Sci. 101: 9333-9338.
16. Kato Jr., T., Delhase, M., Hoffmann, A., and Karin, M. 2003. CK2 is a C-terminal IκB kinase responsible for NF-κB activation during the UV response. Mol. Cell 12: 829-839.
17. Karin, M., Cao, Y., Greten, F.R., and Li, Z.W. 2002. NF-κB in cancer: From innocent bystander to major culprit. Nat. Rev. Cancer 2: 301-310.
18. Kucharczak, J., Simmons, M.J., Fan, Y., and Gelinas, C. 2003. To be, or not to be: NF-κB is the answer-Role of Rel/NF-κB in the regulation of apoptosis. Oncogene 22: 8961-8982.
19. Kucharczak, J.F., Simmons, M.J., Duckett, C.S., and Gelinas, C. 2005. Constitutive proteasome-mediated turnover of Bfl-1/ A1 and its processing in response to TNF receptor activation in FL5-12 pro-B cells convert it into a pro-death factor. Cell. Death Differ. (in press).
20. Kuwana, T., Bouchier-Hayes, L., Chipuk, J.E., Bonzon, C., Sullivan, B.A., Green, D.R., and Newmeyer, D.D. 2005. BH3 domains of BH3-only proteins differentially regulate baxmediated mitochondrial membrane permeabilization both directly and indirectly. Mol. Cell 17: 525-535.
21. Letai, A., Bassik, M.C., Walensky, L.D., Sorcinelli, M.D., Weiler, S., and Korsmeyer, S.J. 2002. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2: 183-192.
22. Leu, J.I., Dumont, P., Hafey, M., Murphy, M.E., and George, D.L. 2004. Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat. Cell Biol. 6: 443-450.
23. Ley, R., Balmanno, K., Hadfield, K., Weston, C., and Cook, S.J. 2003. Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, Bim. J. Biol. Chem. 278: 18811-18816.
24. Lindsten, T., Ross, A.J., King, A., Zong, W.-X., Rathmell, J.C., Shiels, H.A., Ulrich, E., Waymire, K.G., Mahar, P., Frauwirth, K., et al. 2000. The combined functions of the proapoptotic Bcl-2 family members, Bak and Bax, are essential for the normal development of multiple tissues. Mol. Cell 6: 1389-1399.
25. Luciano, F., Jacquel, A., Colosetti, P., Herrant, M., Cagnol, S., Pages, G., and Auberger, P. 2003. Phosphorylation of Bim-EL by Erk1/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function. Oncogene 22: 6785-6793.
26. Marshansky, V., Wang, X., Bertrand, R., Luo, H., Duguid, W., Chinnadurai, G., Kanaan, N., Vu, M.D., and Wu, J. 2001. Proteasomes modulate balance among proapoptotic and antiapoptotic Bcl-2 family members and compromise functioning of the electron transport chain in leukemic cells. J. Immunol. 166: 3130-3142.
27. Michels, J., Johnson, P.W.M., and Packham, G. 2004. Molecules in focus - Mcl-1. Int. J. Biochem. Cell Biol. 37: 267-271.
28. Nelson, D.A., Tan, T.-T., Rabson, A.B., Anderson, D., Degenhardt, K., and White, E. 2004. Hypoxia and defective apoptosis drive genomic instability and tumorigenesis. Genes & Dev. 18: 2095-2107.
29. Nijhawan, D., Fang, M., Traer, E., Zhong, Q., Gao, W., Du, F., and Wang, X. 2003. Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation. Genes & Dev. 17: 1475-1496.
30. Opferman, J.T., Letai, A., Beard, C., Sorcinelli, M.D., Ong, C.C., and Korsmeyer, S. 2003. Development and maintenance of B and T lymphocytes requires antiapoptotic Mcl-1. Nature 426: 671-676.
31. Opferman, J.T., Iwasaki, H., Ong, C.C., Suh, H., Mizuno, S.-I., Akashi, K., and Korsmeyer, S. 2005. Obligate role of antiapoptotic MCL-1 in the survival of hematopoietic stem cells. Science 307: 1101-1104.
32. Perez, D. and White, E. 2000. TNF-α signals apoptosis through a Bid-dependent conformational change in Bax that is inhibited by E1B 19K. Mol. Cell 6: 53-63.
33. Perkins, N.D. 2004. Regulation of NF-κB by atypical activators and tumour suppressors. Biochem. Soc. Trans. 32: 936-939.
34. Puthalakath, H. and Strasser, A. 2002. Keeping killers on a tight leash: Transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins. Cell Death Differ. 9: 505-512.
35. Rajkumar, S.V., Richardson, P.G., Hideshima, T., and Anderson, K.C. 2005. Proteasome inhibition as a novel therapeutic target in human cancer. J. Clin. Oncol. 23: 630-639.
36. Ranger, A.M., Zha, J.P., Harada, H., Datta, S.R., Danial, N.N., Gilmore, A.P., Kutok, J.L., LeBeau, M.M., and Greenberg, M.E. 2003. Bad-deficient mice develop diffuse large B cell lymphoma. Proc. Natl. Acad. Sci. 100: 9324-9329.
37. Rinkenberger, J.L., Horning, S., Klocke, B., Roth, K., and Korsmeyer, S.J. 2000. Mcl-1 deficiency results in peri-implantation embryonic lethality. Genes & Dev. 14: 23-27.
38. L-Bak peptide complex: Recognition between regulators of apoptosis. Science 275: 983-986.
39. Sundararajan, R., Cuconati, A., Nelson, D., and White, E. 2001. Tumor Necrosis factor-α induces Bax-Bak interaction and apoptosis, which is inhibited by adenovirus E1B 19K. J. Biol. Chem. 276: 45120-45127.
40. Suzuki, M., Youle, R.J., and Tjandra, N. 2000. Structure of Bax: Coregulation of dimer formation and intracellular localization. Cell 103: 645-654.
41. Tan, T.-T., Degenhardt, K., Nelson, D.A., Beaudoin, B., Nieves-Neira, W., Bouillet, P., Villunger, A., Adams, J.M., and White, E. 2005. Key roles of BIM-driven apoptosis in epithelial tumors and rational chemotherapy. Cancer Cell 7: 227-238.
42. Wei, M., Zong, W.-X., Cheng, E., Lindsten, T., Panoutsakopoulou, V., Ross, A., Roth, K., MacGregor, G., Thompson, C., and Korsmeyer, S. 2001. Proapoptotic Bax and Bak: A requisite gateway to mitochondrial dysfunction and death. Science 292: 727-730.
43. Wei, M.C., Lindsten, T., Mootha, V.K., Weiler, S., Gross, A., Ashiya, M., Thompson, C.B., and Korsmeyer, S.J. 2000. tBid, a membrane-targeted death ligand, oligomerizes Bak to release cytochrome c. Genes & Dev. 14: 2060-2071.
44. Werner, A.B., de Vries, E., Tait, S.W., Bontjer, I., and Borst, J. 2002. Bcl-2 family member Bfl-1/AI sequesters truncated bid to inhibit is collaboration with pro-apoptotic Bak or Bax. J. Biol. Chem. 277: 22781-22788.
45. L, but not Bcl-2, until displaced by BH3-only proteins. Genes & Dev. (this issue).
46. Zhou, P., Levy, N.B., Xie, H., Qian, L., and Lee, C.Y. 2001. MCL1 transgenic mice exhibit a high incidence of B-cell lymphoma manifested as a spectrum of histologic subtypes. Blood 97: 3902-3909.
47. Zhu, H., Zhang, L., Dong, F., Guo, W., Wu, S., Teraishi, F., Davis, J.J., Chiao, P.J., and Fang, B. 2005. Bik/NBK accumulation correlates with apoptosis-induction by bortezomib (PS-341, Velcade) and other proteasome inhibitors. Oncogene (in press).
48. Zinkel, S.S., Ong, C.C., Ferguson, D.O., Iwasaki, H., Akashi, K., Bronson, R.T., Kutok, J.L., Alt, F.W., and Korsmeyer, S.J. 2003. Proapoptotic BID is required for myeloid homeostasis and tumor suppression. Genes & Dev. 17: 229-239.
49. Zong, W.-X., Lindsten, T., Ross, A.J., MacGregor, G.R., and Thompson, C.B. 2001. BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes & Dev. 15: 1481-1486.